TransMedics Group Statistics
Total Valuation
TMDX has a market cap or net worth of $2.38 billion. The enterprise value is $2.78 billion.
Important Dates
The last earnings date was Tuesday, May 5, 2026, after market close.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TMDX has 34.56 million shares outstanding. The number of shares has increased by 8.45% in one year.
| Current Share Class | 34.56M |
| Shares Outstanding | 34.56M |
| Shares Change (YoY) | +8.45% |
| Shares Change (QoQ) | -11.57% |
| Owned by Insiders (%) | 3.20% |
| Owned by Institutions (%) | 117.60% |
| Float | 33.45M |
Valuation Ratios
The trailing PE ratio is 15.45 and the forward PE ratio is 28.08.
| PE Ratio | 15.45 |
| Forward PE | 28.08 |
| PS Ratio | 3.75 |
| Forward PS | 3.05 |
| PB Ratio | 4.82 |
| P/TBV Ratio | 4.94 |
| P/FCF Ratio | 15.74 |
| P/OCF Ratio | 10.82 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 22.21, with an EV/FCF ratio of 18.39.
| EV / Earnings | 16.19 |
| EV / Sales | 4.38 |
| EV / EBITDA | 22.21 |
| EV / EBIT | 29.48 |
| EV / FCF | 18.39 |
Financial Position
The company has a current ratio of 6.74, with a Debt / Equity ratio of 1.75.
| Current Ratio | 6.74 |
| Quick Ratio | 6.01 |
| Debt / Equity | 1.75 |
| Debt / EBITDA | 6.47 |
| Debt / FCF | 5.70 |
| Interest Coverage | 5.40 |
Financial Efficiency
Return on equity (ROE) is 45.22% and return on invested capital (ROIC) is 13.49%.
| Return on Equity (ROE) | 45.22% |
| Return on Assets (ROA) | 5.19% |
| Return on Invested Capital (ROIC) | 13.49% |
| Return on Capital Employed (ROCE) | 7.03% |
| Weighted Average Cost of Capital (WACC) | 11.86% |
| Revenue Per Employee | $708,118 |
| Profits Per Employee | $191,452 |
| Employee Count | 898 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 5.11 |
Taxes
| Income Tax | -82.59M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.17% in the last 52 weeks. The beta is 2.06, so TMDX's price volatility has been higher than the market average.
| Beta (5Y) | 2.06 |
| 52-Week Price Change | -43.17% |
| 50-Day Moving Average | 97.68 |
| 200-Day Moving Average | 119.48 |
| Relative Strength Index (RSI) | 31.79 |
| Average Volume (20 Days) | 1,934,401 |
Short Selling Information
The latest short interest is 8.32 million, so 24.07% of the outstanding shares have been sold short.
| Short Interest | 8.32M |
| Short Previous Month | 7.61M |
| Short % of Shares Out | 24.07% |
| Short % of Float | 24.87% |
| Short Ratio (days to cover) | 9.27 |
Income Statement
In the last 12 months, TMDX had revenue of $635.89 million and earned $171.92 million in profits. Earnings per share was $4.46.
| Revenue | 635.89M |
| Gross Profit | 375.74M |
| Operating Income | 94.44M |
| Pretax Income | 89.33M |
| Net Income | 171.92M |
| EBITDA | 125.35M |
| EBIT | 94.44M |
| Earnings Per Share (EPS) | $4.46 |
Full Income StatementBalance Sheet
The company has $461.74 million in cash and $863.42 million in debt, with a net cash position of -$401.68 million or -$11.62 per share.
| Cash & Cash Equivalents | 461.74M |
| Total Debt | 863.42M |
| Net Cash | -401.68M |
| Net Cash Per Share | -$11.62 |
| Equity (Book Value) | 494.01M |
| Book Value Per Share | 14.30 |
| Working Capital | 527.36M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $220.23 million and capital expenditures -$68.87 million, giving a free cash flow of $151.36 million.
| Operating Cash Flow | 220.23M |
| Capital Expenditures | -68.87M |
| Depreciation & Amortization | 30.91M |
| Net Borrowing | n/a |
| Free Cash Flow | 151.36M |
| FCF Per Share | $4.38 |
Full Cash Flow StatementMargins
Gross margin is 59.09%, with operating and profit margins of 14.85% and 27.04%.
| Gross Margin | 59.09% |
| Operating Margin | 14.85% |
| Pretax Margin | 14.05% |
| Profit Margin | 27.04% |
| EBITDA Margin | 19.71% |
| EBIT Margin | 14.85% |
| FCF Margin | 23.80% |
Dividends & Yields
TMDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.45% |
| Shareholder Yield | -8.45% |
| Earnings Yield | 7.22% |
| FCF Yield | 6.35% |
Analyst Forecast
The average price target for TMDX is $117.89, which is 71.02% higher than the current price. The consensus rating is "Buy".
| Price Target | $117.89 |
| Price Target Difference | 71.02% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 18.38% |
| EPS Growth Forecast (5Y) | 3.44% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMDX has an Altman Z-Score of 3.46 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.46 |
| Piotroski F-Score | 5 |
